You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 11, 2024

Details for Patent: 10,912,772


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,912,772
Title:Opioid formulations
Abstract:A depot precursor formulation comprising:
Inventor(s):Tiberg Fredrik, Harwigsson Ian, Johnsson Markus
Assignee:Camurus AB
Application Number:US16882186
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 10,912,772

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-001 May 23, 2023 RX Yes No ⤷  Try a Trial ⤷  Try a Trial A METHOD OF ADMINISTERING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE. A METHOD OF TREATING OPIOID WITHDRAWAL USING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE ⤷  Try a Trial
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-002 May 23, 2023 RX Yes No ⤷  Try a Trial ⤷  Try a Trial A METHOD OF ADMINISTERING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE. A METHOD OF TREATING OPIOID WITHDRAWAL USING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE ⤷  Try a Trial
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-003 May 23, 2023 RX Yes No ⤷  Try a Trial ⤷  Try a Trial A METHOD OF ADMINISTERING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE. A METHOD OF TREATING OPIOID WITHDRAWAL USING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE ⤷  Try a Trial
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-004 May 23, 2023 RX Yes No ⤷  Try a Trial ⤷  Try a Trial A METHOD OF ADMINISTERING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE. A METHOD OF TREATING OPIOID WITHDRAWAL USING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE ⤷  Try a Trial
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-005 May 23, 2023 RX Yes No ⤷  Try a Trial ⤷  Try a Trial A METHOD OF ADMINISTERING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE. A METHOD OF TREATING OPIOID WITHDRAWAL USING AN OPIOID MAINTENANCE TREATMENT COMPRISING BUPRENORPHINE ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,912,772

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E401054 ⤷  Try a Trial
Austria E462409 ⤷  Try a Trial
Austria E501710 ⤷  Try a Trial
Australia 2005249274 ⤷  Try a Trial
Australia 2005324794 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.